← Eichor
Study identifier: NCT07467824 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer

Condition: Breast Cancer · Breast Neoplasms  ·  Sponsor: European University Miguel de Cervantes

PhaseNA
Planned participants66
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

Breast cancer (BC) is the most common cancer among women worldwide. Cancer treatments are associated with numerous adverse events that reduce patients' functionality and alter their clinical and molecular profiles. Physical exercise and adherence to nutritional guidelines during treatment and survivorship have been shown to improve recovery prognosis and reduce treatment-related complications. However, the specific effects of prehabilitation, defined as "the process in the cancer continuum that occurs between diagnosis and the start of treatment," remain unknown in BC. A concurrent training program and specific nutritional guidelines during this phase could reduce treatment-related adverse events and improve recovery. Similarly, including a home-based exercise program and nutritional guidelines throughout the cancer treatment continuum could enhance the benefits achieved and improve various aspects of functionality, clinical status, and quality of life. Therefore, the main aim of this randomized controlled trial is to evaluate the impact and effects of a supervised prehabilitation program (combining high-intensity concurrent training and personalized nutritional guidelines) and a supportive care intervention (home-based exercise and personalized nutritional guidelines) on functional, neuromuscular, and cardiorespiratory capacity, quality of life, body composition, and clinical and molecular outcomes in women with BC. In addition, the sustainability of the benefits achieved in…

This description comes directly from the study's public registry record.

Talk to the study team

Alejandro Santos Lozano, PhD  ·  +34 983001000  ·  asantos@uemc.es

Celia García Chico, PhD  ·  +34 983001000  ·  cgarciac@uemc.es

Always discuss trial participation with your own doctor first.

Locations (2)

Hospital Recoletas Campo GrandeValladolid, Valladolid, SpainRecruiting
Miguel de Cervantes European UniversityValladolid, Valladolid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07467824